Aclaris Therapeutics Inc

Company Snapshot
640 Lee Road
Wayne, PA 19087
United States
Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 105
https://www.aclaristx.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$1,349,000
$2,048,000
$17,792,000
Operating Income
($50,912,000)
($65,384,000)
($85,154,000)
Net Income
($51,015,000)
($90,865,000)
($86,908,000)
2020
Gross Profit
$1,349,000
Operating Income
($50,912,000)
Net Income
($51,015,000)
2021
Gross Profit
$2,048,000
Operating Income
($65,384,000)
Net Income
($90,865,000)
2022
Gross Profit
$17,792,000
Operating Income
($85,154,000)
Net Income
($86,908,000)
The above data on Aclaris Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Neal Walker
Chairman of the Board
$943,488
$4,881,039
$12,200
$5,836,727
Neal Walker
$5,836,727
Chairman of the Board
Gail Cawkwell
Chief Medical Officer
$371,166
$2,927,042
$0
$3,298,208
Gail Cawkwell
$3,298,208
Chief Medical Officer
Douglas Manion
Director, President and Chief Executive Officer
$286,326
$2,915,872
$0
$3,202,198
Douglas Manion
$3,202,198
Director, President and Chief Executive Officer
Joseph Monahan
Chief Scientific Officer
$588,000
$2,222,961
$12,021
$2,822,982
Joseph Monahan
$2,822,982
Chief Scientific Officer
Christopher Molineaux
Lead Independent Director
$79,000
$217,554
$0
$296,554
Christopher Molineaux
$296,554
Lead Independent Director
Aclaris Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us